Detalhe da pesquisa
1.
Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan.
Breast Cancer Res Treat
; 202(2): 377-387, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528266
2.
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
Hered Cancer Clin Pract
; 20(1): 11, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313928
3.
BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.
Int J Cancer
; 146(5): 1293-1298, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469414
4.
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.
Hered Cancer Clin Pract
; 18: 16, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32765800
5.
Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer.
Cancers (Basel)
; 13(4)2021 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670479
6.
Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence.
PLoS One
; 14(1): e0208610, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30640897
7.
Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.
PLoS One
; 13(7): e0201065, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30036379